Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: A case report

被引：36

作者：

Husain M.M. ^{[1
]}

Stegman D. ^{[1
]}

Trevino K. ^{[1
]}

机构：

[1] University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8898

来源：

Annals of General Psychiatry | / 4卷 / 1期

关键词：

Depressive Symptom; Bupropion; Preterm Delivery; Vagus Nerve Stimulation; Spontaneous Preterm Delivery;

D O I：

10.1186/1744-859X-4-16

中图分类号：

学科分类号：

摘要：

Background: Depression during pregnancy can have significant health consequences for the mother and her infant. Antidepressant medications, which pass through the placenta, may increase the risk of low birth weight and preterm delivery. The use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may induce serotonergic symptoms in the infant after delivery. Antidepressant medications in breast milk may also be passed to an infant. Vagus nerve stimulation (VNS) therapy is an effective non-pharmacologic treatment for treatment-resistant depression (TRD), but little information exists regarding the use of VNS therapy during pregnancy. Case presentation: The patient began receiving VNS therapy for TRD in March 1999. The therapy was effective, producing substantial reductions in depressive symptoms and improvement of function. In 2002, the patient reported that she was pregnant. She continued receiving VNS therapy throughout her pregnancy, labor, and delivery, which enabled the sustained remission of her depression. The pregnancy was uneventful; a healthy daughter was delivered at full term. Conclusion: In this case, VNS therapy provided effective treatment for TRD during pregnancy and delivery. VNS was safe for the patient and her child. © 2005 Husain et al; licensee BioMed Central Ltd.

引用

页数：7

共 28 条

[1]

Andersson L., Sundstrom-Poromaa I., Bixo M., Wulff M., Bondestam K., Astrom M., Point prevalence of psychiatric disorders during the second trimester of pregnancy: A population-based study, Am. J. Obstet. Gynecol., 189, 1, pp. 148-154, (2003)

[2]

Josefsson A., Berg G., Nordin C., Sydsjo G., Prevalence of depressive symptoms in late pregnancy and postpartum, Acta. Obstet. Gynecol. Scand., 80, 3, pp. 251-255, (2001)

[3]

McKee M.D., Cunningham M., Jankowski K.R., Zayas L., Health-related functional status in pregnancy: Relationship to depression and social support in a multi-ethnic population, Obstet. Gynecol., 97, 6, pp. 988-993, (2001)

[4]

Mental and neurological disorders [prevalence of depression]

[5]

Marcus S.M., Flynn H.A., Blow F.C., Barry K.L., Depressive symptoms among pregnant women screened in obstetrics settings, J. Womens Health (Larchmt), 12, 4, pp. 373-380, (2003)

[6]

Preti A., Cardascia L., Zen T., Pellizzari P., Marchetti M., Favaretto G., Miotto P., Obstetric complications in patients with depression - A population-based case-control study, J. Affect Disord., 61, 1-2, pp. 101-106, (2000)

[7]

Chung T.K., Lau T.K., Yip A.S., Chiu H.F., Lee D.T., Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes, Psychosom. Med., 63, 5, pp. 830-834, (2001)

[8]

Jablensky A.V., Morgan V., Zubrick S.R., Bower C., Yellachich L.A., Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders, Am. J. Psychiatry, 162, 1, pp. 79-91, (2005)

[9]

Kurki T., Hiilesmaa V., Raitasalo R., Mattila H., Ylikorkala O., Depression and anxiety in early pregnancy and risk for preeclampsia, Obstet. Gynecol., 95, 4, pp. 487-490, (2000)

[10]

Orr S.T., James S.A., Blackmore Prince C., Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland, Am. J. Epidemiol., 156, 9, pp. 797-802, (2002)

← 1 2 3 →